
Octapharma Plasma
The family-owned company, Octapharma AG, was established in 1983 with a single idea: that people with Hemophilia deserve access to better treatments.

Jerry Winkelstein helped build IDF’s respected reputation

Foundation Focus: June 2025 update with CEO Jorey Berry

Financial assistance programs can help with medical bills

Foundation sends letter opposing research cuts

How Medicaid cuts could impact a family affected by SCID

Lunch & Learn: Understanding genetic variants in APDS

Update: What RSV preventatives mean for those with PI
Genentech
Genentech is a leading biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Its transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.